A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Hans C. Lee, Jatin J. Shah, Lei Feng, Elisabet E. Manasanch, Rebecca Lu, Ashley Morphey, Brandon Crumpton, Krina K. Patel, Michael L. Wang, Raymond Alexanian, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma'. Together they form a unique fingerprint.